Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.
Source: US Top News and Analysis
Related Posts
Regional sports networks are faltering even as ratings soar
A group of regional sports networks is set to wind down, marking the demise of…
Intel shares jump 9% after buying back Ireland chip fab in sign of renewed strength
The semiconductor company will now wholly own Fab 34 after spending $14.2 billion to repurchase…
Novo Nordisk shares rise after Wegovy recommended by Britain’s drug price regulator
The new recommendation will significantly expand access to Wegovy on the England’s NHS. Source: US…